{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:40:22Z","timestamp":1785325222852,"version":"3.55.0"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNR"],"published-print":{"date-parts":[[2020,9,29]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Multiple viral pathogens can pose a significant health risk to individuals. As a recent\nexample, the &amp;#946;-coronavirus family virion, SARS-CoV-2, has quickly evolved as a pandemic leading\nto coronavirus disease 2019 (COVID-19) and has been declared by the World Health Organization\nas a Public Health Emergency of International Concern. To date, no definitive treatment or\nvaccine application exists for COVID-19. Although new investigations seek to repurpose existing\nantiviral treatments for COVID-19, innovative treatment strategies not normally considered to\nhave antiviral capabilities may be critical to address this global concern. One such avenue that may\nprove to be exceedingly fruitful and offer exciting potential as new antiviral therapy involves the\nmechanistic target of rapamycin (mTOR) and its associated pathways of mTOR Complex 1\n(mTORC1), mTOR Complex 2 (mTORC2), and AMP activated protein kinase (AMPK). Recent\nwork has shown that mTOR pathways in conjunction with AMPK may offer valuable targets to\ncontrol cell injury, oxidative stress, mitochondrial dysfunction, and the onset of hyperinflammation,\na significant disability associated with COVID-19. Furthermore, pathways that can activate\nmTOR may be necessary for anti-hepatitis C activity, reduction of influenza A virus replication,\nand vital for type-1 interferon responses with influenza vaccination. Yet, important considerations\nfor the development of safe and effective antiviral therapy with mTOR pathways exist. Under\nsome conditions, mTOR can act as a double edge sword and participate in virion replication and\nvirion release from cells. Future work with mTOR as a potential antiviral target is highly warranted\nand with a greater understanding of this novel pathway, new treatments against several viral\npathogens may successfully emerge.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567202617666200425205122","type":"journal-article","created":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T06:34:36Z","timestamp":1587882876000},"page":"332-337","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment"],"prefix":"10.2174","volume":"17","author":[{"given":"Kenneth","family":"Maiese","sequence":"first","affiliation":[{"name":"Cellular and Molecular Signaling, New York, NY 10022, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/jcm9040941","volume":"9","author":"Borges do Nascimento I.J.","year":"2020","unstructured":"Borges do Nascimento I.J.; Cacic N.; Abdulazeem H.M.; Novel Coronavirus infection (COVID-19) in humans: A scoping review and meta-analysis. J Clin Med 2020,9(4),941","journal-title":"J Clin Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11684-019-0733-5","volume":"2","author":"Zhou M.","year":"2020","unstructured":"Zhou M.; Zhang X.; Qu J.; Coronavirus disease 2019 (COVID-19): A clinical update. Front Med 2020,2,1-10","journal-title":"Front Med"},{"key":"ref=3","year":"2020","unstructured":"2020"},{"key":"ref=4","author":"Bayham J","year":"2020","unstructured":"Bayham J; Fenichel EP;  2020"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"Sungnak W.","year":"2020","unstructured":"Sungnak W.; Huang N.; Becavin C.; SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 2020,26,681-687","journal-title":"Nat Med"},{"key":"ref=6","volume":"2020","author":"McGonagle D.","year":"2020","unstructured":"McGonagle D.; Sharif K.; O\u2019Regan A.; Bridgewood C.; The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev 2020,2020","journal-title":"Autoimmun Rev"},{"key":"ref=7","first-page":"1","volume":"34","author":"Conti P.","year":"2020","unstructured":"Conti P.; Ronconi G.; Caraffa A.; Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 2020,34(2),1","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=8","first-page":"1","volume":"2020","author":"Fadini G.P.","year":"2020","unstructured":"Fadini G.P.; Morieri M.L.; Longato E.; Avogaro A.; Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 2020,2020,1-3","journal-title":"J Endocrinol Invest"},{"key":"ref=9","volume":"1","author":"Bloch E.M.","year":"2020","unstructured":"Bloch E.M.; Shoham S.; Casadevall A.; Sachais B.S.; Shaz B.; Winters J.L.; Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020,1","journal-title":"J Clin Invest"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","volume":"52","author":"Amanat F.","year":"2020","unstructured":"Amanat F.; Krammer F.; SARS-CoV-2 Vaccines: Status Report. Immunity 2020,52(4),583-589","journal-title":"Immunity"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","volume":"133","author":"Fan H.H.","year":"2020","unstructured":"Fan H.H.; Wang L.Q.; Liu W.L.; Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model. Chin Med J (Engl) 2020,133(9),1051-1056","journal-title":"Chin Med J (Engl)"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12539-019-00347-6","volume":"12","author":"Dorvash M.","year":"2020","unstructured":"Dorvash M.; Farahmandnia M.; Tavassoly I.; a systems biology roadmap to decode mTOR control system in cancer. Interdiscip Sci 2020,12(1),1-11","journal-title":"Interdiscip Sci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17512433.2020.1698288","volume":"13","author":"Maiese K.","year":"2020","unstructured":"Maiese K.; Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways. Expert Rev Clin Pharmacol 2020,13(1),23-34","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-019-0498-0","volume":"18","author":"Pan Y.R.","year":"2020","unstructured":"Pan Y.R.; Song J.Y.; Fan B.; mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors. Cell Commun Signal 2020,18(1),27","journal-title":"Cell Commun Signal"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"Xu F.","year":"2020","unstructured":"Xu F.; Na L.; Li Y.; Chen L.; Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020,10,54","journal-title":"Cell Biosci"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/bcp.12804","volume":"82","author":"Maiese K.","year":"2016","unstructured":"Maiese K.; Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 2016,82(5),1245-1266","journal-title":"Br J Clin Pharmacol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/1673-5374.179032","volume":"11","author":"Maiese K.","year":"2016","unstructured":"Maiese K.; Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Neural Regen Res 2016,11(3),372-385","journal-title":"Neural Regen Res"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","volume":"19","author":"Maiese K.","year":"2013","unstructured":"Maiese K.; Chong Z.Z.; Shang Y.C.; Wang S.; mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med 2013,19(1),51-60","journal-title":"Trends Mol Med"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.18632\/aging.100872","volume":"8","author":"Walters H.E.","year":"2016","unstructured":"Walters H.E.; Deneka-Hannemann S.; Cox L.S.; Reversal of phenotypes of cellular senescence by pan-mTOR inhibition. Aging (Albany NY) 2016,8(2),231","journal-title":"Aging (Albany NY)"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BST20170121","volume":"46","author":"Maiese K.","year":"2018","unstructured":"Maiese K.; The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): Oversight for neurodegenerative disorders. Biochem Soc Trans 2018,46(2),351-360","journal-title":"Biochem Soc Trans"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10735-019-09825-z","volume":"50","author":"Huang D.","year":"2019","unstructured":"Huang D.; Shen S.; Cai M.; Role of mTOR complex in IGF-1 induced neural differentiation of DPSCs. J Mol Histol 2019,50(3),273-283","journal-title":"J Mol Histol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1567202615666180319151244","volume":"15","author":"Maiese K.","year":"2018","unstructured":"Maiese K.; Novel treatment strategies for the nervous system: circadian clock genes, non-coding RNAs, and forkhead transcription factors. Curr Neurovasc Res 2018,15(1),81-91","journal-title":"Curr Neurovasc Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1002\/jcp.26276","volume":"233","author":"Soltani A.","year":"2017","unstructured":"Soltani A.; Bahreyni A.; Boroumand N.; Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status and perspectives. J Cell Physiol 2017,233(6),4783-4790","journal-title":"J Cell Physiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12868-018-0482-4","volume":"19","author":"Zimmerman M.A.","year":"2018","unstructured":"Zimmerman M.A.; Biggers C.D.; Li P.A.; Rapamycin treatment increases hippocampal cell viability in an mTOR-independent manner during exposure to hypoxia mimetic, cobalt chloride. BMC Neurosci 2018,19(1),82","journal-title":"BMC Neurosci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"14693","DOI":"10.1074\/jbc.C109.002907","volume":"284","author":"Wang L.","year":"2009","unstructured":"Wang L.; Lawrence J.C.; Sturgill T.W.; Harris T.E.; Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. J Biol Chem 2009,284(22),14693-14697","journal-title":"J Biol Chem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s12035-017-0524-4","volume":"55","author":"Beker M.C.","year":"2018","unstructured":"Beker M.C.; Caglayan B.; Yalcin E.; Time-of-day dependent neuronal injury after ischemic stroke: Implication of circadian clock transcriptional factor bmal1 and survival kinase AKT. Mol Neurobiol 2018,55(3),2565-2576","journal-title":"Mol Neurobiol"},{"key":"ref=27","volume":"7","author":"Chong Z.Z.","year":"2012","unstructured":"Chong Z.Z.; Shang Y.C.; Wang S.; Maiese K.; PRAS40 Is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection. PLoS One 2012,7(9)","journal-title":"PLoS One"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1074\/jbc.M800723200","volume":"283","author":"Wang L.","year":"2008","unstructured":"Wang L.; Harris T.E.; Lawrence J.C.; Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J Biol Chem 2008,283(23),15619-15627","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156720212803530618","volume":"9","author":"Shang Y.C.","year":"2012","unstructured":"Shang Y.C.; Chong Z.Z.; Wang S.; Maiese K.; WNT1 Inducible Signaling Pathway Protein 1 (WISP1) targets PRAS40 to govern beta-amyloid apoptotic injury of microglia. Curr Neurovasc Res 2012,9(4),239-249","journal-title":"Curr Neurovasc Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellsig.2011.08.010","volume":"24","author":"Wang H.","year":"2012","unstructured":"Wang H.; Zhang Q.; Wen Q.; Proline-rich Akt substrate of 40kDa (PRAS40): A novel downstream target of PI3k\/Akt signaling pathway. Cell Signal 2012,24(1),17-24","journal-title":"Cell Signal"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molcel.2011.08.030","volume":"44","author":"Gao D.","year":"2011","unstructured":"Gao D.; Inuzuka H.; Tan M.K.; mTOR Drives Its Own Activation via SCF(betaTrCP)-Dependent Degradation of the mTOR Inhibitor DEPTOR. Mol Cell 2011,44(2),290-303","journal-title":"Mol Cell"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1097-2765(03)00114-X","volume":"11","author":"Kim D.H.","year":"2003","unstructured":"Kim D.H.; Sarbassov D.D.; Ali S.M.; GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 2003,11(4),895-904","journal-title":"Mol Cell"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4103\/1673-5374.249224","volume":"14","author":"Maiese K.","year":"2019","unstructured":"Maiese K.; Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho\/Rock. Neural Regen Res 2019,14(5),773-774","journal-title":"Neural Regen Res"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"Jacinto E.","year":"2004","unstructured":"Jacinto E.; Loewith R.; Schmidt A.; Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004,6(11),1122-1128","journal-title":"Nat Cell Biol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","volume":"416","author":"Garcia-Martinez J.M.","year":"2008","unstructured":"Garcia-Martinez J.M.; Alessi D.R.; mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 2008,416(3),375-385","journal-title":"Biochem J"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20102103","volume":"436","author":"Pearce L.R.","year":"2011","unstructured":"Pearce L.R.; Sommer E.M.; Sakamoto K.; Wullschleger S.; Alessi D.R.; Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J 2011,436(1),169-179","journal-title":"Biochem J"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","volume":"16","author":"Frias M.A.","year":"2006","unstructured":"Frias M.A.; Thoreen C.C.; Jaffe J.D.; Schroder W.; Sculley T.; Carr S.A.; mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 2006,16(18),1865-1870","journal-title":"Curr Biol"},{"key":"ref=38","author":"An T.","year":"2020","unstructured":"An T.; Zhang X.; Li H.; GPR120 facilitates cholesterol efflux in macrophages through activation of AMPK signaling pathway. FEBS J [Epub ahead of print].2020","journal-title":"FEBS J"},{"key":"ref=39","first-page":"299","volume":"14","author":"Maiese K.","year":"2017","unstructured":"Maiese K.; Moving to the rhythm with clock (circadian) genes, autophagy, mTOR, and SIRT1 in degenerative disease and cancer. Curr Neurovasc Res 2017,14(3),299-304","journal-title":"Curr Neurovasc Res"},{"key":"ref=40","author":"Maiese K.","year":"2020","unstructured":"Maiese K.; Prospects and perspectives for WISP1 (CCN4) in Diabetes Mellitus. Curr Neurovasc Res [Epub ahead of print].2020","journal-title":"Curr Neurovasc Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JME-19-0080","volume":"63","author":"Pal P.B.","year":"2019","unstructured":"Pal P.B.; Sonowal H.; Shukla K.; Srivastava S.K.; Ramana K.V.; Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1\/AMPK-alpha1\/mTOR pathway. J Mol Endocrinol 2019,63(1),11-25","journal-title":"J Mol Endocrinol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13105-019-00678-4","volume":"75","author":"Shokri Afra H.","year":"2019","unstructured":"Shokri Afra H.; Zangooei M.; Meshkani R.; Hesperetin is a potent bioactivator that activates SIRT1-AMPK signaling pathway in HepG2 cells. J Physiol Biochem 2019,75(2),125-133","journal-title":"J Physiol Biochem"},{"key":"ref=43","first-page":"2279","volume":"43","author":"Zhao D.","year":"2019","unstructured":"Zhao D.; Sun X.; Lv S.; Salidroside attenuates oxidized lowdensity lipoproteininduced endothelial cell injury via promotion of the AMPK\/SIRT1 pathway. Int J Mol Med 2019,43(6),2279-2290","journal-title":"Int J Mol Med"},{"key":"ref=44","author":"Kowalska M.","year":"2020","unstructured":"Kowalska M.; Piekut T.; Prendecki M.; Sodel A.; Kozubski W.; Dorszewska J.; Mitochondrial and nuclear DNA oxidative damage in physiological and pathological aging. DNA Cell Biol [Epub ahead of print].2020","journal-title":"DNA Cell Biol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnmol.2020.00028","volume":"13","author":"Wu L.","year":"2020","unstructured":"Wu L.; Xiong X.; Wu X.; Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci 2020,13,28","journal-title":"Front Mol Neurosci"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.18632\/aging.101966","volume":"11","author":"Wang N.","year":"2019","unstructured":"Wang N.; Luo Z.; Jin M.; Exploration of age-related mitochondrial dysfunction and the anti-aging effects of resveratrol in zebrafish retina. Aging (Albany NY) 2019,11(10),3117-3137","journal-title":"Aging (Albany NY)"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12199-018-0757-5","volume":"24","author":"Zhao Y.","year":"2019","unstructured":"Zhao Y.; Wang Q.; Wang Y.; Li J.; Lu G.; Liu Z.; Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K\/Akt signaling pathway in parkinsonian cell model. Environ Health Prev Med 2019,24(1),4","journal-title":"Environ Health Prev Med"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.11.006","volume":"159","author":"Atef M.M.","year":"2019","unstructured":"Atef M.M.; El-Sayed N.M.; Ahmed A.A.M.; Mostafa Y.M.; Donepezil improves neuropathy through activation of AMPK signalling pathway in streptozotocin-induced diabetic mice. Biochem Pharmacol 2019,159,1-10","journal-title":"Biochem Pharmacol"},{"key":"ref=49","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/875961","volume":"2015","author":"Maiese K.","year":"2015","unstructured":"Maiese K.; New Insights for oxidative stress and Diabetes Mellitus. Oxid Med Cell Longev 2015,2015","journal-title":"Oxid Med Cell Longev"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1567202613666161129112822","volume":"14","author":"Maiese K.","year":"2017","unstructured":"Maiese K.; Harnessing the power of SIRT1 and non-coding RNAs in vascular disease. Curr Neurovasc Res 2017,14(1),82-88","journal-title":"Curr Neurovasc Res"},{"key":"ref=51","author":"Peixoto CA","year":"2017","unstructured":"Peixoto CA; de Oliveira WH; da Rocha Araujo SM; Nunes AKS;  2017"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"12783","DOI":"10.1074\/jbc.M809207200","volume":"284","author":"Sato T.","year":"2009","unstructured":"Sato T.; Nakashima A.; Guo L.; Tamanoi F.; Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J Biol Chem 2009,284(19),12783-12791","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"Inoki K.","year":"2003","unstructured":"Inoki K.; Zhu T.; Guan K.L.; TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003,115(5),577-590","journal-title":"Cell"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1567202611666140912115107","volume":"11","author":"Maiese K.","year":"2014","unstructured":"Maiese K.; WISP1: Clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res 2014,11(4),378-389","journal-title":"Curr Neurovasc Res"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/cancers12030532","volume":"12","author":"Gallyas F.","year":"2020","unstructured":"Gallyas F.; Sumegi B.; Szabo C.; Role of Akt activation in PARP inhibitor resistance in cancer. Cancers (Basel) 2020,12(3),532","journal-title":"Cancers (Basel)"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12906-018-2215-8","volume":"18","author":"Chang H.","year":"2018","unstructured":"Chang H.; Yuan W.; Wu H.; Yin X.; Xuan H.; Bioactive components and mechanisms of Chinese poplar propolis alleviates oxidized low-density lipoprotein-induced endothelial cells injury. BMC Complement Altern Med 2018,18(1),142","journal-title":"BMC Complement Altern Med"},{"key":"ref=57","first-page":"1765","volume":"8","author":"Kamarudin M.N.","year":"2014","unstructured":"Kamarudin M.N.; Mohd Raflee N.A.; Syed Hussein S.S.; Lo J.Y.; Supriady H.; Abdul Kadir H.; (R)-(+)-alpha-Lipoic acid protected NG108-15 cells against H2O2-induced cell death through PI3K-Akt\/GSK-3beta pathway and suppression of NF-kappabeta-cytokines. Drug Des Devel Ther 2014,8,1765-1780","journal-title":"Drug Des Devel Ther"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s11064-016-2056-0","volume":"41","author":"Cheng P.","year":"2016","unstructured":"Cheng P.; Zuo X.; Ren Y.; Adenosine A1-receptors modulate mtor signaling to regulate white matter inflammatory lesions induced by chronic cerebral hypoperfusion. Neurochem Res 2016,41(12),3272-3277","journal-title":"Neurochem Res"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1111\/bph.12655","volume":"171","author":"Jiang T.","year":"2014","unstructured":"Jiang T.; Yu J.T.; Zhu X.C.; Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy. Br J Pharmacol 2014,171(13),3146-3157","journal-title":"Br J Pharmacol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"Klionsky D.J.","year":"2016","unstructured":"Klionsky D.J.; Abdelmohsen K.; Abe A.; Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2016,12(1),1-222","journal-title":"Autophagy"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14728222.2012.719499","volume":"16","author":"Maiese K.","year":"2012","unstructured":"Maiese K.; Chong Z.Z.; Shang Y.C.; Wang S.; Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 2012,16(12),1203-1214","journal-title":"Expert Opin Ther Targets"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"Kalender A.","year":"2010","unstructured":"Kalender A.; Selvaraj A.; Kim S.Y.; Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 2010,11(5),390-401","journal-title":"Cell Metab"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db12-0533","volume":"62","author":"He C.","year":"2013","unstructured":"He C.; Zhu H.; Li H.; Zou M.H.; Xie Z.; Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2013,62(4),1270-1281","journal-title":"Diabetes"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ddr.21400","volume":"78","author":"Oda S.S.","year":"2017","unstructured":"Oda S.S.; Metformin protects against experimental acrylamide neuropathy in rats. Drug Dev Res 2017,78(7),349-359","journal-title":"Drug Dev Res"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1753-0407.12989","volume":"12","author":"Hsia S.H.","year":"2020","unstructured":"Hsia S.H.; Duran P.; Lee M.L.; Davidson M.B.; Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes 2020,12(1),91-94","journal-title":"J Diabetes"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/v8100287","volume":"8","author":"Shives K.D.","year":"2016","unstructured":"Shives K.D.; Massey A.R.; May N.A.; Morrison T.E.; Beckham J.D.; 4EBP-dependent signaling supports west nile virus growth and protein expression. Viruses 2016,8(10),287","journal-title":"Viruses"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00535-011-0481-z","volume":"47","author":"Takeshita S.","year":"2012","unstructured":"Takeshita S.; Ichikawa T.; Taura N.; Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells. J Gastroenterol 2012,47(2),195-202","journal-title":"J Gastroenterol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2014.00187","volume":"5","author":"Nandagopal N.","year":"2014","unstructured":"Nandagopal N.; Ali A.K.; Komal A.K.; Lee S.H.; The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions. Front Immunol 2014,5,187","journal-title":"Front Immunol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4149\/av_2018_109","volume":"62","author":"Seong R.K.","year":"2018","unstructured":"Seong R.K.; Kim J.A.; Shin O.S.; Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways. Acta Virol 2018,62(1),78-85","journal-title":"Acta Virol"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41598-020-60213-0","volume":"10","author":"Saenwongsa W.","year":"2020","unstructured":"Saenwongsa W.; Nithichanon A.; Chittaganpitch M.; Metformin-induced suppression of IFN-alpha via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes. Sci Rep 2020,10(1),3229","journal-title":"Sci Rep"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1099\/jgv.0.001356","volume":"101","author":"Johri M.K.","year":"2020","unstructured":"Johri M.K.; Lashkari H.V.; Gupta D.; Vedagiri D.; Harshan K.H.; mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication events. J Gen Virol 2020,101(1),86-95","journal-title":"J Gen Virol"}],"container-title":["Current Neurovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181324\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:26:05Z","timestamp":1613838365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181324\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567202617666200425205122","relation":{},"ISSN":["1567-2026"],"issn-type":[{"value":"1567-2026","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}